XENE · Xenon Pharmaceuticals Inc.
$62.35
-1.88 (-2.93%)
At close · Aug 14
Market Cap
$6.04B
Shares
96.84M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding XENE
302 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| SMALLCAP World Fund Inc | — | 3,501,794 | $203,629,321 | 0.25% | Long | 2026-03-31 | |
| VANGUARD HEALTH CARE FUND | — | 2,676,154 | $149,971,670 | 0.41% | Long | 2026-04-30 | |
| iShares Russell 2000 ETF | — | 2,109,700 | $122,679,055 | 0.17% | Long | 2026-03-31 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | — | 1,937,648 | $106,047,475 | 0.04% | Long | 2026-05-31 | |
| Select Health Care Portfolio | — | 1,150,000 | $62,939,500 | 1.09% | Long | 2026-05-31 | |
| Fidelity Small Cap Index Fund | — | 854,538 | $47,888,310 | 0.15% | Long | 2026-04-30 | |
| iShares Russell 2000 Growth ETF | — | 704,118 | $40,944,462 | 0.34% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 598,390 | $34,796,379 | 0.43% | Long | 2026-03-31 | |
| Fidelity Advisor Health Care Fund | — | 600,000 | $33,624,000 | 1.16% | Long | 2026-04-30 | |
| Fidelity Small Cap Growth Fund | — | 582,621 | $32,650,081 | 0.39% | Long | 2026-04-30 | |
| Fidelity Stock Selector Small Cap Fund | — | 546,385 | $30,619,415 | 0.44% | Long | 2026-04-30 | |
| Federated Hermes Kaufmann Fund | — | 522,500 | $29,280,900 | 0.63% | Long | 2026-04-30 | |
| Small Cap Growth Fund | — | 510,246 | $28,594,186 | 0.56% | Long | 2026-04-30 | |
| Fidelity Contrafund | — | 483,388 | $28,109,012 | 0.02% | Long | 2026-03-31 | |
| Bridge Builder Small/Mid Cap Growth Fund | — | 472,520 | $27,477,038 | 0.30% | Long | 2026-03-31 | |
| Janus Henderson Triton Fund | — | 461,139 | $26,815,233 | 0.52% | Long | 2026-03-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 450,789 | $26,213,380 | 0.21% | Long | 2026-03-31 | |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | — | 440,241 | $25,600,014 | 0.31% | Long | 2026-03-31 | |
| Fidelity Advisor Biotechnology Fund | — | 456,458 | $25,579,906 | 1.34% | Long | 2026-04-30 | |
| JPMorgan Mid Cap Growth Fund | — | 425,997 | $24,771,726 | 0.22% | Long | 2026-03-31 | |
| Federated Hermes Kaufmann Small Cap Fund | — | 438,500 | $24,573,540 | 0.85% | Long | 2026-04-30 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 443,946 | $24,297,165 | 0.14% | Long | 2026-05-31 | |
| Fidelity U.S. Equity Central Fund | — | 400,000 | $23,260,000 | 0.11% | Long | 2026-03-31 | |
| JPMorgan Small Cap Growth Fund | — | 399,508 | $23,231,390 | 1.07% | Long | 2026-03-31 | |
| abrdn Healthcare Investors | HQH | 389,621 | $22,656,461 | 1.99% | Long | 2026-03-31 | |
| Fidelity Series Small Cap Opportunities Fund | — | 384,471 | $21,545,755 | 0.43% | Long | 2026-04-30 | |
| Invesco Discovery Fund | — | 391,284 | $21,414,973 | 0.27% | Long | 2026-05-31 | |
| T. Rowe Price Small-Cap Stock Fund, Inc. | — | 356,478 | $20,729,196 | 0.26% | Long | 2026-03-31 | |
| Putnam Small Cap Growth Fund | — | 354,797 | $20,631,446 | 0.76% | Long | 2026-03-31 | |
| Janus Henderson Global Life Sciences Fund | — | 348,546 | $20,267,950 | 0.39% | Long | 2026-03-31 | |
| AB Small Cap Growth Portfolio | — | 354,631 | $19,873,521 | 0.68% | Long | 2026-04-30 | |
| Driehaus Small Cap Growth Fund | — | 335,773 | $19,525,200 | 1.70% | Long | 2026-03-31 | |
| Harbor Small Cap Growth Fund | — | 345,004 | $19,334,024 | 0.75% | Long | 2026-04-30 | |
| Select Biotechnology Portfolio | — | 345,564 | $18,912,718 | 0.36% | Long | 2026-05-31 | |
| Loomis Sayles Small Cap Growth Fund | — | 315,982 | $18,374,353 | 0.95% | Long | 2026-03-31 | |
| Fidelity Small Cap Growth K6 Fund | — | 295,393 | $16,553,824 | 0.39% | Long | 2026-04-30 | |
| AB DISCOVERY GROWTH FUND, INC. | — | 292,115 | $16,370,125 | 0.61% | Long | 2026-04-30 | |
| Janus Henderson Venture Fund | — | 246,945 | $14,359,852 | 0.47% | Long | 2026-03-31 | |
| PGIM Jennison Health Sciences Fund | — | 252,941 | $13,843,461 | 1.00% | Long | 2026-05-29 | |
| Select Pharmaceuticals Portfolio | — | 226,000 | $12,368,980 | 0.82% | Long | 2026-05-31 | |
| VIP Health Care Portfolio | — | 208,000 | $12,095,200 | 1.20% | Long | 2026-03-31 | |
| abrdn Life Sciences Investors | HQL | 202,664 | $11,784,912 | 2.10% | Long | 2026-03-31 | |
| Franklin Small Cap Growth Fund | — | 200,051 | $11,210,858 | 0.46% | Long | 2026-04-30 | |
| Fidelity Advisor New Insights Fund | — | 192,400 | $11,188,060 | 0.05% | Long | 2026-03-31 | |
| BlackRock Advantage Small Cap Core Fund | — | 197,710 | $10,820,668 | 0.21% | Long | 2026-05-29 | |
| T. Rowe Price Institutional Small-Cap Stock Fund | — | 183,516 | $10,671,455 | 0.25% | Long | 2026-03-31 | |
| Schwab Small-Cap Index Fund | — | 189,730 | $10,632,469 | 0.15% | Long | 2026-04-30 | |
| AST Small-Cap Equity Portfolio | — | 179,492 | $10,437,460 | 0.56% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | — | 149,164 | $8,673,887 | 0.02% | Long | 2026-03-31 | |
| Master Small Cap Index Series | — | 140,450 | $8,167,168 | 0.17% | Long | 2026-03-31 |
Showing 1–50 of 302 positions
Key facts
CIK
1582313
CUSIP
98420N105
13F (30d)
307 filings
301 filers
Visit website
Investor relations